Organism name | Paeonia albiflora |
---|---|
Genus | Paeonia |
Family | Paeoniaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Paeonia lactiflora |
---|---|
Linked NCBI taxonomy ID | 35924 |
Linked level | species |
Family in NCBI taxonomy | Paeoniaceae |
---|---|
ID | 24943 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | eudicotyledons |
---|---|
ID | 71240 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00005182
![]() |
Kaempferol 3,7-diglucoside
/ Kaempferol 3,7-O-beta-D-diglucopyranoside |
CHEMBL2206209
|
No. 1 | No. 15 |
![]() |
|||
C00004565
![]() |
Kaempferol
/ Nimbecetin / Rhamnolutein / Pelargidenolon / 5,7,4'-Trihydroxyflavonol / 3,5,7,4'-Tetrahydroxyflavone / 3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one |
CHEMBL150
|
C006552
|
76 / 69 / 87 | 86 / 8 | No. 71 | No. 15 |
![]() |
C00048039
![]() |
Paeonidanin C
/ (-)-Paeonidanin C |
CHEMBL1078414
|
No. 1069 |
![]() |
||||
C00048037
![]() |
Paeonidanin A
/ (-)-Paeonidanin A |
CHEMBL1078412
|
No. 1069 |
![]() |
||||
C00048038
![]() |
Paeonidanin B
/ (-)-Paeonidanin B |
CHEMBL1078413
|
No. 1069 |
![]() |
||||
C00003011
![]() |
Paeoniflorin
|
CHEMBL1078549
CHEMBL1397567 CHEMBL1972762 |
C015423
|
4 / 4 / 8 | 3 / 2 | No. 1566 |
![]() |
|
C00033623
![]() |
Albiflorin
|
CHEMBL1939883
|
C014959
|
1 / 1 / 1 | No. 1566 |
![]() |
||
C00000207
![]() |
Benzoic acid
|
CHEMBL541
|
D019817
|
97 / 39 / 33 | 24 / 1 | No. 2192 |
![]() |
|
C00048040
![]() |
Paeonidanin D
/ (-)-Paeonidanin D |
CHEMBL1078415
|
No. 5019 |
![]() |
||||
C00048041
![]() |
Paeonidanin E
/ (-)-Paeonidanin E |
CHEMBL1078416
|
No. 5019 |
![]() |
||||
C00010954
![]() |
Paeoniflorigenone
/ (+)-Paeoniflorigenone |
CHEMBL1077668
|
C042713
|
No. 5422 |
![]() |
|||
C00048036
![]() |
Paeonidangenin
/ (-)-Paeonidangenin |
CHEMBL1081704
|
No. 5422 |
![]() |
||||
C00002664
![]() |
Phenol
|
CHEMBL14060
|
D019800
|
111 / 52 / 47 | 101 / 30 | No. 6006 |
![]() |
|
C00048042
![]() |
Paeoniflorone
/ (-)-Paeoniflorone |
CHEMBL1081882
|
No. 6538 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P03372 | Estrogen receptor | NR3A1 | C00000207 C00002664 C00003011 C00004565 C00033623 | 1 / 1 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000207 C00002664 C00004565 | 0 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000207 C00002664 C00004565 | 0 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00000207 C00002664 C00004565 | 1 / 8 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000207 C00002664 C00004565 | 1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00000207 C00002664 C00004565 | 1 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000207 C00002664 C00004565 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00000207 C00002664 C00004565 | 0 / 1 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000207 C00002664 C00004565 | 1 / 1 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000207 C00002664 C00004565 | 0 / 3 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00000207 C00002664 C00004565 | 2 / 2 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000207 C00002664 C00004565 | 0 / 1 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00000207 C00002664 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00000207 C00002664 | 0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00000207 C00002664 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00000207 C00002664 | 0 / 0 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00000207 C00002664 | 0 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00000207 C00002664 | 1 / 1 |
P10275 | Androgen receptor | NR3C4 | C00002664 C00004565 | 3 / 4 |
P29466 | Caspase-1 | C14 | C00000207 C00002664 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00000207 C00002664 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00000207 C00002664 | 0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00002664 C00004565 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00000207 C00002664 | 2 / 2 |
P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | C00000207 C00002664 | 0 / 0 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00000207 C00002664 | 0 / 0 |
P08246 | Neutrophil elastase | S1A | C00000207 C00002664 | 2 / 1 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00000207 C00002664 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00000207 C00002664 | 0 / 0 |
P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00002664 C00004565 | 0 / 0 |
P00918 | Carbonic anhydrase 2 | Lyase | C00000207 C00002664 | 1 / 2 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00000207 C00002664 | 0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00000207 C00002664 | 1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | C00000207 C00002664 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00000207 C00002664 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00000207 C00002664 | 1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00000207 C00002664 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00000207 C00002664 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00000207 C00002664 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00000207 C00002664 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00000207 C00002664 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00000207 C00002664 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00000207 C00002664 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00000207 C00002664 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00000207 C00002664 | 0 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00000207 C00002664 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00000207 C00002664 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00000207 C00002664 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00000207 C00002664 | 1 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | C00000207 C00002664 | 0 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00000207 C00002664 | 1 / 0 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00000207 C00002664 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00000207 C00002664 | 0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00002664 C00004565 | 1 / 1 |
O00255 | Menin | Unclassified protein | C00003011 C00004565 | 2 / 5 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00000207 C00002664 | 2 / 0 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00003011 C00004565 | 1 / 2 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00000207 C00002664 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00000207 C00002664 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00000207 C00002664 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00000207 C00002664 | 0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00000207 C00002664 | 2 / 1 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00000207 C00002664 | 0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00000207 C00002664 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00000207 C00002664 | 1 / 1 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00000207 C00002664 | 1 / 0 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00000207 C00002664 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00000207 C00002664 | 1 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00000207 C00002664 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00003011 C00004565 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00000207 C00002664 | 3 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00000207 C00002664 | 0 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00000207 C00002664 | 0 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00000207 C00002664 | 0 / 0 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00000207 C00002664 | 1 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00000207 C00002664 | 5 / 9 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00000207 C00002664 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00000207 C00002664 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00000207 C00002664 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00000207 C00002664 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00000207 C00002664 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00000207 C00002664 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00000207 C00002664 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00000207 C00002664 | 0 / 0 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00002664 C00004565 | 5 / 3 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00000207 C00002664 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00000207 C00002664 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00000207 C00002664 | 1 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00000207 C00002664 | 2 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00000207 C00002664 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00000207 C00002664 | 0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00000207 C00002664 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00000207 C00002664 | 1 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00000207 C00002664 | 0 / 0 |
P03956 | Interstitial collagenase | M10A | C00000207 C00002664 | 0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00000207 C00002664 | 0 / 0 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00000207 C00002664 | 2 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00000207 C00002664 | 0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00004565 | 0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | C00004565 | 1 / 1 |
Q9GZT4 | Serine racemase | Enzyme | C00000207 | 0 / 0 |
Q12791 | Calcium-activated potassium channel subunit alpha-1 | KCNM, KCa1.x | C00004565 | 1 / 1 |
P14679 | Tyrosinase | Oxidoreductase | C00004565 | 4 / 2 |
P27487 | Dipeptidyl peptidase 4 | S9B | C00004565 | 0 / 1 |
P00915 | Carbonic anhydrase 1 | Lyase | C00002664 | 0 / 0 |
P15121 | Aldose reductase | Enzyme | C00004565 | 0 / 0 |
O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00000207 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00004565 | 0 / 0 |
Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | C00004565 | 4 / 4 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00004565 | 0 / 0 |
P06276 | Cholinesterase | Hydrolase | C00004565 | 0 / 0 |
P36888 | Receptor-type tyrosine-protein kinase FLT3 | Pdgfr | C00004565 | 1 / 1 |
O43570 | Carbonic anhydrase 12 | Lyase | C00002664 | 1 / 2 |
Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00002664 | 0 / 0 |
P06280 | Alpha-galactosidase A | Enzyme | C00002664 | 1 / 1 |
P04745 | Alpha-amylase 1 | Enzyme | C00004565 | 0 / 0 |
Q96RI1 | Bile acid receptor | NR1H4 | C00004565 | 0 / 0 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00004565 | 0 / 0 |
Q9Y3R4 | Sialidase-2 | Enzyme | C00004565 | 0 / 0 |
P23280 | Carbonic anhydrase 6 | Lyase | C00002664 | 0 / 0 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | C00004565 | 0 / 0 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00002664 | 0 / 1 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00004565 | 3 / 3 |
Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | C00004565 | 2 / 0 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00004565 | 2 / 2 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00004565 | 0 / 0 |
Q9GZU7 | Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 | Enzyme | C00004565 | 0 / 0 |
P14920 | D-amino-acid oxidase | Enzyme | C00000207 | 0 / 0 |
Q15078 | Cyclin-dependent kinase 5 activator 1 | REG serine/threonine protein kinase family | C00004565 | 0 / 0 |
Q00535 | Cyclin-dependent kinase 5 | Cdk5 | C00004565 | 0 / 0 |
Q9UQ49 | Sialidase-3 | Enzyme | C00000207 | 0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | C00004565 | 1 / 0 |
P04066 | Tissue alpha-L-fucosidase | Enzyme | C00002664 | 1 / 2 |
P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | C00004565 | 0 / 0 |
P11309 | Serine/threonine-protein kinase pim-1 | Pim | C00004565 | 0 / 0 |
Q00534 | Cyclin-dependent kinase 6 | CMGC serine/threonine protein kinase family | C00004565 | 1 / 0 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00004565 | 1 / 1 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00004565 | 0 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00000207 | 3 / 2 |
P37059 | Estradiol 17-beta-dehydrogenase 2 | Enzyme | C00004565 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00004565 | 11 / 10 |
Q99489 | D-aspartate oxidase | Enzyme | C00000207 | 0 / 0 |
P98170 | E3 ubiquitin-protein ligase XIAP | Other cytosolic protein | C00004565 | 1 / 1 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00004565 | 0 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00004565 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00004565 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00004565 | 4 / 3 |
Q8N1Q1 | Carbonic anhydrase 13 | Lyase | C00002664 | 0 / 0 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00004565 | 0 / 0 |
P43166 | Carbonic anhydrase 7 | Lyase | C00002664 | 0 / 0 |
P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00002664 | 0 / 0 |
Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00002664 | 0 / 0 |
P04062 | Glucosylceramidase | Enzyme | C00004565 | 6 / 4 |
Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00004565 | 0 / 0 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00004565 | 0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00004565 | 1 / 1 |
P07451 | Carbonic anhydrase 3 | Lyase | C00002664 | 0 / 0 |
O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | C00000207 | 0 / 0 |
Q04760 | Lactoylglutathione lyase | Enzyme | C00004565 | 0 / 0 |
P35869 | Aryl hydrocarbon receptor | Transcription Factor | C00004565 | 0 / 0 |
Q9NPH5 | NADPH oxidase 4 | Enzyme | C00004565 | 0 / 0 |
P48147 | Prolyl endopeptidase | S9A | C00004565 | 0 / 0 |
P22748 | Carbonic anhydrase 4 | Lyase | C00002664 | 1 / 1 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00004565 | 0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00004565 | 7 / 37 |
P33527 | Multidrug resistance-associated protein 1 | drugs | C00004565 | 0 / 0 |
P14061 | Estradiol 17-beta-dehydrogenase 1 | Enzyme | C00004565 | 0 / 0 |
O95067 | G2/mitotic-specific cyclin-B2 | Other cytosolic protein | C00004565 | 0 / 0 |
P14635 | G2/mitotic-specific cyclin-B1 | Other cytosolic protein | C00004565 | 0 / 0 |
P06493 | Cyclin-dependent kinase 1 | Cdc2 | C00004565 | 0 / 0 |
Q8WWL7 | G2/mitotic-specific cyclin-B3 | Other cytosolic protein | C00004565 | 0 / 0 |
P18507 | Gamma-aminobutyric acid receptor subunit gamma-2 | GABA-A gamma | C00002664 | 4 / 2 |
P47870 | Gamma-aminobutyric acid receptor subunit beta-2 | GABA-A beta | C00002664 | 0 / 0 |
P14867 | Gamma-aminobutyric acid receptor subunit alpha-1 | GABA-A alpha | C00002664 | 1 / 1 |
P49840 | Glycogen synthase kinase-3 alpha | Gsk | C00004565 | 0 / 0 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | C00004565 | 0 / 0 |
Q9H0H5 | Rac GTPase-activating protein 1 | Unclassified protein | C00004565 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00002664
C00004565
|
7296 | TXNRD1, GRIM-12, TR, TR1, TRXR1, TXNR | thioredoxin reductase 1 (EC:1.8.1.9) |
C00000207
C00002664
|
1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00000207
C00002664
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00000207
C00002664
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00003011
C00004565
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00002664
C00004565
|
4502 | MT2A, MT2 | metallothionein 2A |
C00000207
C00004565
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00002664
C00004565
|
3043 | HBB, CD113t-C, beta-globin | hemoglobin, beta |
C00002664
C00004565
|
3014 | H2AFX, H2A.X, H2A/X, H2AX | H2A histone family, member X |
C00002664
C00004565
|
2938 | GSTA1, GST2, GSTA1-1, GTH1 | glutathione S-transferase alpha 1 (EC:2.5.1.18) |
C00000207
C00004565
|
2729 | GCLC, GCL, GCS, GLCL, GLCLC | glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) |
C00000207
C00004565
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00002664
C00004565
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00002664
C00004565
|
10140 | TOB1, APRO6, PIG49, TOB, TROB, TROB1 | transducer of ERBB2, 1 |
C00002664
|
983 | CDK1, CDC2, CDC28A, P34CDC2 | cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) |
C00004565
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00004565
|
1031 | CDKN2C, INK4C, p18, p18-INK4C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
C00004565
|
1080 | CFTR, ABC35, ABCC7, CF, CFTR/MRP, MRP7, TNR-CFTR, dJ760C5.1 | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49) |
C00004565
|
1147 | CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16 | conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) |
C00004565
|
1401 | CRP, PTX1 | C-reactive protein, pentraxin-related |
C00004565
|
1437 | CSF2, GMCSF | colony stimulating factor 2 (granulocyte-macrophage) |
C00004565
|
37618 |
C00004565
|
||
54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00004565
|
5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00004565
|
6352 | CCL5, D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228, eoCP | chemokine (C-C motif) ligand 5 |
C00004565
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00004565
|
1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00004565
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00004565
|
1734 | DIO2, 5DII, D2, DIOII, SelY, TXDI2 | deiodinase, iodothyronine, type II (EC:1.97.1.10) |
C00004565
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00004565
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00004565
|
2203 | FBP1, FBP | fructose-1,6-bisphosphatase 1 (EC:3.1.3.11) |
C00004565
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00004565
|
4616 | GADD45B, GADD45BETA, MYD118 | growth arrest and DNA-damage-inducible, beta |
C00004565
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00004565
|
9687 | GREB1 | growth regulation by estrogen in breast cancer 1 |
C00004565
|
598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00004565
|
2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00004565
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00004565
|
27113 | BBC3, JFY-1, JFY1, PUMA | BCL2 binding component 3 |
C00004565
|
3082 | HGF, DFNB39, F-TCF, HGFB, HPTA, SF | hepatocyte growth factor (hepapoietin A; scatter factor) |
C00004565
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00004565
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00004565
|
3565 | IL4, BCGF-1, BCGF1, BSF-1, BSF1, IL-4 | interleukin 4 |
C00004565
|
3567 | IL5, EDF, IL-5, TRF | interleukin 5 (colony-stimulating factor, eosinophil) |
C00004565
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00004565
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00004565
|
4297 | KMT2A, ALL-1, CXXC7, HRX, HTRX1, MLL, MLL/GAS7, MLL1A, TET1-MLL, TRX1, WDSTS | lysine (K)-specific methyltransferase 2A (EC:2.1.1.43) |
C00004565
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00004565
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00004565
|
4233 | MET, AUTS9, HGFR, RCCP2, c-Met | met proto-oncogene (EC:2.7.10.1) |
C00004565
|
110357 |
C00004565
|
||
472 | ATM, AT1, ATA, ATC, ATD, ATDC, ATE, TEL1, TELO1 | ataxia telangiectasia mutated (EC:2.7.11.1) |
C00004565
|
4586 | MUC5AC, MUC5, TBM, leB | mucin 5AC, oligomeric mucus/gel-forming |
C00004565
|
8202 | NCOA3, ACTR, AIB-1, AIB1, CAGH16, CTG26, KAT13B, RAC3, SRC-3, SRC3, TNRC14, TNRC16, TRAM-1, bHLHe42, pCIP | nuclear receptor coactivator 3 (EC:2.3.1.48) |
C00004565
|
4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00004565
|
4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00004565
|
4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) |
C00004565
|
8856 | NR1I2, BXR, ONR1, PAR, PAR1, PAR2, PARq, PRR, PXR, SAR, SXR | nuclear receptor subfamily 1, group I, member 2 |
C00004565
|
9970 | NR1I3, CAR, CAR1, MB67 | nuclear receptor subfamily 1, group I, member 3 |
C00004565
|
5241 | PGR, NR3C3, PR | progesterone receptor |
C00004565
|
10891 | PPARGC1A, LEM6, PGC-1(alpha), PGC-1v, PGC1, PGC1A, PPARGC1 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
C00004565
|
8000 | PSCA, PRO232 | prostate stem cell antigen |
C00004565
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00004565
|
6119 | RPA3, REPA3 | replication protein A3, 14kDa |
C00004565
|
2810 | SFN, YWHAS | stratifin |
C00004565
|
6513 | SLC2A1, DYT17, DYT18, DYT9, EIG12, GLUT, GLUT1, GLUT1DS, HTLVR, PED | solute carrier family 2 (facilitated glucose transporter), member 1 |
C00004565
|
6773 | STAT2, ISGF-3, P113, STAT113 | signal transducer and activator of transcription 2, 113kDa |
C00004565
|
7019 | TFAM, MTTF1, MTTFA, TCF6, TCF6L1, TCF6L2, TCF6L3 | transcription factor A, mitochondrial |
C00004565
|
7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00004565
|
7039 | TGFA, TFGA | transforming growth factor, alpha |
C00004565
|
405 | ARNT, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA, TANGO, bHLHe2 | aryl hydrocarbon receptor nuclear translocator |
C00004565
|
239 | ALOX12, 12-LOX, 12S-LOX, LOG12 | arachidonate 12-lipoxygenase (EC:1.13.11.31) |
C00004565
|
9540 | TP53I3, PIG3 | tumor protein p53 inducible protein 3 |
C00004565
|
8626 | TP63, AIS, B(p51A), B(p51B), EEC3, KET, LMS, NBP, OFC8, RHS, SHFM4, TP53CP, TP53L, TP73L, p40, p51, p53CP, p63, p73H, p73L | tumor protein p63 |
C00004565
|
7161 | TP73, P73 | tumor protein p73 |
C00004565
|
7352 | UCP3, SLC25A9 | uncoupling protein 3 (mitochondrial, proton carrier) |
C00004565
|
54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00004565
|
54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00004565
|
54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) |
C00004565
|
54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00004565
|
54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00004565
|
54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00004565
|
7402 | UTRN, DMDL, DRP, DRP1 | utrophin |
C00004565
|
8839 | WISP2, CCN5, CT58, CTGF-L | WNT1 inducible signaling pathway protein 2 |
C00004565
|
664 | BNIP3, NIP3 | BCL2/adenovirus E1B 19kDa interacting protein 3 |
C00003011
|
3091 | HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
C00003011
|
10965 | ACOT2, CTE-IA, CTE1A, MTE1, PTE2, PTE2A, ZAP128 | acyl-CoA thioesterase 2 (EC:3.1.2.2) |
C00002664
|
174 | AFP, FETA, HPAFP | alpha-fetoprotein |
C00002664
|
213 | ALB, PRO0883, PRO0903, PRO1341 | albumin |
C00002664
|
249 | ALPL, AP-TNAP, APTNAP, HOPS, TNAP, TNSALP | alkaline phosphatase, liver/bone/kidney (EC:3.1.3.1) |
C00002664
|
25805 | BAMBI, NMA | BMP and activin membrane-bound inhibitor |
C00002664
|
8553 | BHLHE40, BHLHB2, DEC1, HLHB2, SHARP-2, STRA13, Stra14 | basic helix-loop-helix family, member e40 |
C00002664
|
10904 | BLCAP, BC10 | bladder cancer associated protein |
C00002664
|
813 | CALU | calumenin |
C00002664
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00002664
|
890 | CCNA2, CCN1, CCNA | cyclin A2 |
C00002664
|
9469 | CHST3, C6ST, C6ST1, HSD | carbohydrate (chondroitin 6) sulfotransferase 3 (EC:2.8.2.17) |
C00002664
|
9076 | CLDN1, CLD1, ILVASC, SEMP1 | claudin 1 |
C00002664
|
1277 | COL1A1, OI4 | collagen, type I, alpha 1 |
C00002664
|
1385 | CREB1, CREB | cAMP responsive element binding protein 1 |
C00002664
|
100160140 |
C00002664
|
||
1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) |
C00002664
|
4051 | CYP4F3, CPF3, CYP4F, LTB4H | cytochrome P450, family 4, subfamily F, polypeptide 3 (EC:1.14.13.30) |
C00002664
|
26528 | DAZAP1 | DAZ associated protein 1 |
C00002664
|
55802 | DCP1A, HSA275986, Nbla00360, SMAD4IP1, SMIF | decapping mRNA 1A |
C00002664
|
1654 | DDX3X, DBX, DDX14, DDX3, HLP2 | DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked (EC:3.6.4.13) |
C00002664
|
1843 | DUSP1, CL100, HVH1, MKP-1, MKP1, PTPN10 | dual specificity phosphatase 1 (EC:3.1.3.16 3.1.3.48) |
C00002664
|
22936 | ELL2 | elongation factor, RNA polymerase II, 2 |
C00002664
|
2114 | ETS2, ETS2IT1 | v-ets avian erythroblastosis virus E26 oncogene homolog 2 |
C00002664
|
355 | FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6 | Fas cell surface death receptor |
C00002664
|
26190 | FBXW2, FBW2, Fwd2, Md6 | F-box and WD repeat domain containing 2 |
C00002664
|
8061 | FOSL1, FRA, FRA1, fra-1 | FOS-like antigen 1 |
C00002664
|
2623 | GATA1, ERYF1, GATA-1, GF-1, GF1, NF-E1, NFE1, XLANP, XLTDA, XLTT | GATA binding protein 1 (globin transcription factor 1) |
C00002664
|
2624 | GATA2, DCML, MONOMAC, NFE1B | GATA binding protein 2 |
C00002664
|
9329 | GTF3C4, KAT12, TFIII90, TFIIIC290, TFIIIC90, TFIIICDELTA | general transcription factor IIIC, polypeptide 4, 90kDa (EC:2.3.1.48) |
C00002664
|
26762 | HAVCR1, HAVCR, HAVCR-1, KIM-1, KIM1, TIM, TIM-1, TIM1, TIMD-1, TIMD1 | hepatitis A virus cellular receptor 1 |
C00002664
|
3280 | HES1, HES-1, HHL, HRY, bHLHb39 | hes family bHLH transcription factor 1 |
C00002664
|
3145 | HMBS, PBG-D, PBGD, PORC, UPS | hydroxymethylbilane synthase (EC:2.5.1.61) |
C00002664
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00004565
|
3188 | HNRNPH2, FTP3, HNRPH', HNRPH2, hnRNPH' | heterogeneous nuclear ribonucleoprotein H2 (H') |
C00002664
|
3399 | ID3, HEIR-1, bHLHb25 | inhibitor of DNA binding 3, dominant negative helix-loop-helix protein |
C00002664
|
3552 | IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1 | interleukin 1, alpha |
C00002664
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00002664
|
54556 | ING3, Eaf4, ING2, MEAF4, p47ING3 | inhibitor of growth family, member 3 |
C00002664
|
7071 | KLF10, EGR-alpha, EGRA, TIEG, TIEG1 | Kruppel-like factor 10 |
C00002664
|
1316 | KLF6, BCD1, CBA1, COPEB, CPBP, GBF, PAC1, ST12, ZF9 | Kruppel-like factor 6 |
C00002664
|
3840 | KPNA4, IPOA3, QIP1, SRP3 | karyopherin alpha 4 (importin alpha 3) |
C00002664
|
4041 | LRP5, BMND1, EVR1, EVR4, HBM, LR3, LRP7, OPPG, OPS, OPTA1, VBCH2 | low density lipoprotein receptor-related protein 5 |
C00002664
|
10905 | MAN1A2, MAN1B | mannosidase, alpha, class 1A, member 2 (EC:3.2.1.113) |
C00002664
|
4170 | MCL1, BCL2L3, EAT, MCL1-ES, MCL1L, MCL1S, Mcl-1, TM, bcl2-L-3, mcl1/EAT | myeloid cell leukemia sequence 1 (BCL2-related) |
C00002664
|
4247 | MGAT2, CDG2A, CDGS2, GLCNACTII, GNT-II, GNT2 | mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase (EC:2.4.1.143) |
C00002664
|
4353 | MPO | myeloperoxidase (EC:1.11.2.2) |
C00002664
|
740 | MRPL49, C11orf4, L49mt, MRP-L49, NOF, NOF1 | mitochondrial ribosomal protein L49 |
C00002664
|
4496 | MT1H, MT-0, MT-1H, MT-IH, MT1 | metallothionein 1H |
C00002664
|
4501 | MT1X, MT-1l, MT1 | metallothionein 1X |
C00002664
|
4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00002664
|
4778 | NFE2, NF-E2, p45 | nuclear factor, erythroid 2 |
C00002664
|
4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00002664
|
4800 | NFYA, CBF-A, CBF-B, HAP2, NF-YA | nuclear transcription factor Y, alpha |
C00002664
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00004565
|
8431 | NR0B2, SHP, SHP1 | nuclear receptor subfamily 0, group B, member 2 |
C00002664
|
57162 | PELI1 | pellino E3 ubiquitin protein ligase 1 |
C00002664
|
8864 | PER2, FASPS, FASPS1 | period circadian clock 2 |
C00002664
|
5293 | PIK3CD, P110DELTA, PI3K, p110D | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta (EC:2.7.1.153) |
C00002664
|
5292 | PIM1, PIM | pim-1 oncogene (EC:2.7.11.1) |
C00002664
|
9240 | PNMA1, MA1 | paraneoplastic Ma antigen 1 |
C00002664
|
5411 | PNN, DRS, DRSP, SDK3, memA | pinin, desmosome associated protein |
C00002664
|
10908 | PNPLA6, NTE, NTEMND, SPG39, iPLA2delta, sws | patatin-like phospholipase domain containing 6 (EC:3.1.1.5) |
C00002664
|
5468 | PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma | peroxisome proliferator-activated receptor gamma |
C00002664
|
8493 | PPM1D, PP2C-DELTA, WIP1 | protein phosphatase, Mg2+/Mn2+ dependent, 1D (EC:3.1.3.16) |
C00002664
|
5591 | PRKDC, DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, XRCC7, p350 | protein kinase, DNA-activated, catalytic polypeptide (EC:2.7.11.1) |
C00002664
|
38175 |
C00002664
|
||
9367 | RAB9A, RAB9 | RAB9A, member RAS oncogene family |
C00002664
|
29803 | REPIN1, AP4, RIP60, ZNF464, Zfp464 | replication initiator 1 |
C00002664
|
10670 | RRAGA, FIP-1, FIP1, RAGA | Ras-related GTP binding A |
C00002664
|
51282 | SCAND1, RAZ1, SDP1 | SCAN domain containing 1 |
C00002664
|
22928 | SEPHS2, SPS2, SPS2b | selenophosphate synthetase 2 (EC:2.7.9.3) |
C00002664
|
150094 | SIK1, MSK, SIK, SNF1LK | salt-inducible kinase 1 (EC:2.7.11.1) |
C00002664
|
23411 | SIRT1, SIR2L1 | sirtuin 1 |
C00002664
|
9990 | SLC12A6, ACCPN, KCC3, KCC3A, KCC3B | solute carrier family 12 (potassium/chloride transporter), member 6 |
C00002664
|
6426 | SRSF1, ASF, SF2, SF2p33, SFRS1, SRp30a | serine/arginine-rich splicing factor 1 |
C00002664
|
6430 | SRSF5, HRS, SFRS5, SRP40 | serine/arginine-rich splicing factor 5 |
C00002664
|
51188 | SS18L2, KIAA-iso | synovial sarcoma translocation gene on chromosome 18-like 2 |
C00002664
|
6879 | TAF7, TAF2F, TAFII55 | TAF7 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 55kDa |
C00002664
|
23435 | TARDBP, ALS10, TDP-43 | TAR DNA binding protein |
C00002664
|
10732 | TCFL5, CHA, E2BP-1, Figlb, bHLHe82 | transcription factor-like 5 (basic helix-loop-helix) |
C00002664
|
7014 | TERF2, TRBF2, TRF2 | telomeric repeat binding factor 2 |
C00002664
|
7037 | TFRC, CD71, T9, TFR, TFR1, TR, TRFR, p90 | transferrin receptor |
C00002664
|
7050 | TGIF1, HPE4, TGIF | TGFB-induced factor homeobox 1 |
C00002664
|
10440 | TIMM17A, TIM17, TIM17A | translocase of inner mitochondrial membrane 17 homolog A (yeast) |
C00002664
|
7082 | TJP1, ZO-1 | tight junction protein 1 |
C00002664
|
7128 | TNFAIP3, A20, OTUD7C, TNFA1P2 | tumor necrosis factor, alpha-induced protein 3 (EC:3.4.19.12) |
C00002664
|
27242 | TNFRSF21, BM-018, CD358, DR6 | tumor necrosis factor receptor superfamily, member 21 |
C00002664
|
891 | CCNB1, CCNB | cyclin B1 |
C00004565
|
10221 | TRIB1, C8FW, GIG-2, GIG2, SKIP1, TRB-1, TRB1 | tribbles pseudokinase 1 |
C00002664
|
7286 | TUFT1 | tuftelin 1 |
C00002664
|
4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00004565
|
7357 | UGCG, GCS, GLCT1 | UDP-glucose ceramide glucosyltransferase (EC:2.4.1.80) |
C00002664
|
8876 | VNN1, HDLCQ8, Tiff66 | vanin 1 (EC:3.5.1.92) |
C00002664
|
7444 | VRK2 | vaccinia related kinase 2 (EC:2.7.11.1) |
C00002664
|
231 | AKR1B1, ADR, ALDR1, ALR2, AR | aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) |
C00000207
|
57016 | AKR1B10, AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI | aldo-keto reductase family 1, member B10 (aldose reductase) (EC:1.1.1.2) |
C00000207
|
1645 | AKR1C1, 2-ALPHA-HSD, 20-ALPHA-HSD, C9, DD1, DD1/DD2, DDH, DDH1, H-37, HAKRC, HBAB, MBAB | aldo-keto reductase family 1, member C1 (EC:1.3.1.20 1.1.1.149 1.1.1.112) |
C00000207
|
8644 | AKR1C3, DD3, DDX, HA1753, HAKRB, HAKRe, HSD17B5, PGFS, hluPGFS | aldo-keto reductase family 1, member C3 (EC:1.3.1.20 1.1.1.188 1.1.1.239 1.1.1.64 1.1.1.112 1.1.1.357) |
C00000207
|
2235 | FECH, EPP, FCE | ferrochelatase (EC:4.99.1.1) |
C00000207
|
2512 | FTL, NBIA3 | ferritin, light polypeptide |
C00000207
|
2539 | G6PD, G6PD1 | glucose-6-phosphate dehydrogenase (EC:1.1.1.49) |
C00000207
|
2730 | GCLM, GLCLR | glutamate-cysteine ligase, modifier subunit (EC:6.3.2.2) |
C00000207
|
2936 | GSR | glutathione reductase (EC:1.8.1.7) |
C00000207
|
4097 | MAFG, hMAF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G |
C00000207
|
4199 | ME1, HUMNDME, MES | malic enzyme 1, NADP(+)-dependent, cytosolic (EC:1.1.1.40) |
C00000207
|
4489 | MT1A, MT1, MT1S, MTC | metallothionein 1A |
C00000207
|
4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) |
C00000207
|
5226 | PGD, 6PGD | phosphogluconate dehydrogenase (EC:1.1.1.44) |
C00000207
|
22949 | PTGR1, LTB4DH, PGR1, ZADH3 | prostaglandin reductase 1 (EC:1.3.1.48 1.3.1.74) |
C00000207
|
6566 | SLC16A1, HHF7, MCT, MCT1 | solute carrier family 16 (monocarboxylate transporter), member 1 |
C00000207
|
140809 | SRXN1, C20orf139, Npn3, SRX, SRX1 | sulfiredoxin 1 (EC:1.8.98.2) |
C00000207
|
7295 | TXN, TRDX, TRX, TRX1 | thioredoxin |
C00000207
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#614490 | Blood group, junior system; jr |
Q9UNQ0
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
%606641 | Body mass index; bmi |
P37231
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#607208 | Dravet syndrome |
P18507
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#607681 | Epilepsy, childhood absence, susceptibility to, 2; eca2 |
P18507
|
#611136 | Epilepsy, juvenile myoclonic, susceptibility to, 5; ejm5 |
P14867
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#301500 | Fabry disease |
P06280
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#230000 | Fucosidosis |
P04066
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#609446 | Generalized epilepsy and paroxysmal dyskinesia; gepd |
Q12791
|
#604233 | Generalized epilepsy with febrile seizures plus, type 1; gefsp1 |
P18507
|
#611277 | Generalized epilepsy with febrile seizures plus, type 3; gefsp3 |
P18507
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
#231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
#137760 | Glaucoma, primary open angle; poag |
Q16678
|
#137800 | Glioma susceptibility 1; glm1 |
P04626
P37231 |
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#601626 | Leukemia, acute myeloid; aml |
P36888
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#300635 | Lymphoproliferative syndrome, x-linked, 2; xlp2 |
P98170
|
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#159900 | Myoclonic dystonia |
P14416
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#601665 | Obesity |
P32245
P37231 |
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#604229 | Peters anomaly |
Q16678
|
#172700 | Pick disease of brain |
P10636
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
%612223 | Stature quantitative trait locus 11; stqtl11 |
Q00534
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
#610379 | West nile virus, susceptibility to |
P51681
|
#278300 | Xanthinuria, type i |
P47989
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
P04637 (marker) Q16790 (marker) |
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00141 | Fucosidosis |
P04066
(related)
|
H00422 | Glycoproteinoses |
P04066
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
P27487 (marker) P37231 (related) |
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00125 | Fabry disease |
P06280
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00808 | Idiopathic generalized epilepsies (IGEs) |
P14867
(related)
P18507 (related) |
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00783 | Febrile seizures |
P18507
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00003 | Acute myeloid leukemia (AML) |
P36888
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00107 | Other well-defined immunodeficiency syndromes |
P98170
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H01258 | Generalized epilepsy and paroxysmal dyskinesia (GEPD) |
Q12791
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00612 | Primary open angle glaucoma |
Q16678
(related)
|
H01075 | Peters anomaly |
Q16678
(related)
|
H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D003877 | Dermatitis, Contact |
C00002664
C00000207 |
D005756 | Gastritis |
C00002664
|
D009202 | Cardiomyopathies |
C00004565
|
D002318 | Cardiovascular Diseases |
C00004565
|
D006943 | Hyperglycemia |
C00004565
|
D007938 | Leukemia |
C00004565
|
D010024 | Osteoporosis |
C00004565
|
D011297 | Prenatal Exposure Delayed Effects |
C00004565
|
D000647 | Amnesia |
C00003011
|
D007022 | Hypotension |
C00003011
|
D058186 | Acute Kidney Injury |
C00002664
|
D001855 | Bone Marrow Diseases |
C00002664
|
D001859 | Bone Neoplasms |
C00002664
|
D001913 | Bowen's Disease |
C00002664
|
D003128 | COMA |
C00002664
|
D003556 | Cystitis |
C00002664
|
D017449 | Dermatitis, Allergic Contact |
C00002664
|
D050197 | Atherosclerosis |
C00004565
|
D004382 | Duodenitis |
C00002664
|
D004487 | Edema |
C00002664
|
D001943 | Breast Neoplasms |
C00004565
|
D006417 | Hematuria |
C00002664
|
D006470 | Hemorrhage |
C00002664
|
D006973 | Hypertension |
C00002664
|
D007035 | Hypothermia |
C00002664
|
D055623 | Keratosis, Actinic |
C00002664
|
D048629 | Micronuclei, Chromosome-Defective |
C00002664
|
D009784 | Occupational Diseases |
C00002664
|
D010146 | Pain |
C00002664
|
D020734 | Parkinsonian Disorders |
C00002664
|
D010392 | Pemphigus |
C00002664
|
D010523 | Peripheral Nervous System Diseases |
C00002664
|
D010864 | Pilonidal Sinus |
C00002664
|
D011041 | Poisoning |
C00002664
|
D012131 | Respiratory Insufficiency |
C00002664
|
D013088 | Spermatocele |
C00002664
|
D006848 | Testicular Hydrocele |
C00002664
|
D014202 | Tremor |
C00002664
|
D014277 | Trigeminal Neuralgia |
C00002664
|
D014860 | Warts |
C00002664
|